AusCann: Shaping the future of Medicinal Cannabis




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: AusCann: Shaping the future of Medicinal Cannabis
Released on: December 06, 2016. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    When consumed, Cannabinoids bind to receptor sites in the brain & body mimicking the naturally occurring Endocannabinoids produced in human bodies.
  • Summary
  • Participants
When consumed, Cannabinoids bind to receptor sites in the brain & body mimicking the naturally occurring Endocannabinoids produced in human bodies. Elaine Darby, Managing Director of AusCann, explains to Fintan Walton, CEO of PharmaVentures how Global sentiment is changing toward the use of medicinal cannabis, with an increasing number of jurisdictions legislating in favour of the use.
Elaine holds a Bachelor of Science in Biochemistry & Microbiology, Honours in Molecular Biology and a Bachelor of Laws. Previous roles have included as a lawyer with top tier corporate law firm Clayton Utz, Media and Communications Officer for an Australian Federal Member of Parliament, and Managing Director and Senior Winemaker of Aquila Estate Winery where she was an award winning wine-maker and also involved in international business development and marketing in territories including Singapore, Japan, Canada, the United Kingdom, and the United States. Elaine is currently investment director of Biologica Ventures Pty Ltd which provides investment opportunities as well as project and clinical trial management for digital health and biotechnology companies.